Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease (Q44023499)

29 November 2017

title

Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

29 November 2017

main subject

0 references

Lactobacillus reuteri

object named as

Lactobacillus reuteri

1 reference

2

1 reference

29 November 2017

Haydn L Atkins

1

1 reference

29 November 2017

Luca D Prisciandaro

3

1 reference

29 November 2017

Ashok K Pattanaik

4

1 reference

29 November 2017

Rebecca E A Forder

5

1 reference

29 November 2017

Mark S Turner

6

1 reference

29 November 2017

Gordon S Howarth

7

1 reference

29 November 2017

publication date

26 October 2011

1 reference

Digestive Diseases and Sciences

29 November 2017

published in

1 reference

29 November 2017

volume

57

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

713-719

1 reference

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Probiotics in inflammatory bowel disease--therapeutic rationale and role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Host-bacterial interactions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Multistep mechanism of probiotic bacterium, the effect on innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Cystathionine gamma-lyase is a component of cystine-mediated oxidative defense in Lactobacillus reuteri BR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Identification and characterization of a basic cell surface-located protein from Lactobacillus fermentum BR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

BspA (CyuC) in Lactobacillus fermentum BR11 is a highly expressed high-affinity L-cystine-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Cystine uptake prevents production of hydrogen peroxide by Lactobacillus fermentum BR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Genetic modification of a vaginal strain of Lactobacillus fermentum and its maintenance within the reproductive tract after intravaginal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1943-0

Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats

21 January 2018

1 reference

12 December 2020

Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats

1 reference

12 December 2020

Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease

1 reference

12 December 2020

The Relationship Between the Concentration of Dextran Sodium Sulfate and the Degree of Induced Experimental Colitis in Weanling Rats

1 reference

12 December 2020

The Effect of Exopolysaccharide-Producing Probiotic Strains on Gut Oxidative Damage in Experimental Colitis

1 reference

12 December 2020

Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium

1 reference

12 December 2020

Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats

1 reference

12 December 2020

Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats

1 reference

12 December 2020

Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium

1 reference

12 December 2020

A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis

1 reference

12 December 2020

Colonic mucins in ulcerative colitis: evidence for loss of sulfation

1 reference

12 December 2020

Prebiotic and synbiotic fructooligosaccharide administration fails to reduce the severity of experimental colitis in rats

1 reference

12 December 2020

The bspA locus of Lactobacillus fermentum BR11 encodes an L-cystine uptake system.

1 reference

12 December 2020

10.1007/S10620-011-1943-0

Identifiers

DOI

1 reference

29 November 2017

1 reference